Company Filing History:
Years Active: 2020
Title: Joseph Hanna: Innovator in Optical Glucose Assays
Introduction
Joseph Hanna is a notable inventor based in Burbank, CA. He has made significant contributions to the field of optical glucose assays, holding a total of 2 patents. His work focuses on enhancing the accuracy and efficiency of glucose measurement techniques.
Latest Patents
Joseph Hanna's latest patents include innovations in modified-dextrans for use in optical glucose assays. The invention is directed to a competitive glucose binding affinity assay that comprises a glucose receptor, typically mannan binding lectin, labeled with an assay fluorophore. Additionally, a modified glucose analog, typically dextran, is labeled with a reference fluorophore. In certain embodiments, the glucose analog is coupled to both a reference fluorophore and a quencher dye, such as hexamethoxy crystal violet-1. The reference fluorophore is optionally blue shifted relative to the assay fluorophore, enhancing the assay's effectiveness.
Career Highlights
Joseph Hanna is currently employed at Medtronic Minimed, Inc., where he continues to develop innovative solutions in the medical technology sector. His work has been instrumental in advancing glucose monitoring techniques, which are crucial for diabetes management.
Collaborations
Joseph has collaborated with notable colleagues, including Tri T Dang and Soren Aasmul, contributing to a dynamic and innovative work environment.
Conclusion
Joseph Hanna's contributions to the field of optical glucose assays demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of glucose measurement technologies, which have the potential to significantly impact healthcare practices.